dejunchem 发表于 2013-6-5 18:14:36

多肽药物发展的未来方向

Highlights • An unprecedented number of peptide therapeutics have recently been approved. • Clinical pipeline analysis reveals an emphasis on peptides with enhanced properties. • Development of innovative glucagon-like peptide (GLP)-1 receptor agonists is a strong growth area. • Peptide–drug conjugates and constrained peptides hold promise as new therapeutics.

syjohn 发表于 2013-6-7 10:10:22

没看到相关的文献下载？难道楼主忘了？

dejunchem 发表于 2013-6-8 19:37:17

syjohn 发表于 2013-6-7 10:10 static/image/common/back.gif
没看到相关的文献下载？难道楼主忘了？

http://www.sciencedirect.com/science/article/pii/S1359644613001578
不好意思哈
我上传不上来~~

页: [1]
查看完整版本: 多肽药物发展的未来方向